GGrantIndex
← Search

Developmental Funds

$297,361P30FY2019CANIH

Beckman Research Institute/City Of Hope, Duarte CA

Investigators

Linked publications, trials & patents

Trial NCT07664670Trial NCT07664579Trial NCT07650656Trial NCT07628894Trial NCT07619599Trial NCT07612085Trial NCT07611370Trial NCT07608627Trial NCT07608458Trial NCT07608445Trial NCT07595874Trial NCT07590583Trial NCT07583810Trial NCT07583303Trial NCT07582172Trial NCT07582159Trial NCT07578077Trial NCT07578025Trial NCT07544992Trial NCT07365306Trial NCT07363408Trial NCT07293403Trial NCT07288034Trial NCT07278856Trial NCT07275216Trial NCT07271355Trial NCT07235501Trial NCT07226544Trial NCT07226102Trial NCT07225855Trial NCT07225738Trial NCT07220447Trial NCT07219147Trial NCT07218913Trial NCT07218718Trial NCT07218692Trial NCT07218510Trial NCT07210086Trial NCT07202247Trial NCT07184294Trial NCT07136493Trial NCT07133997Trial NCT07128680Trial NCT07126301Trial NCT07125729Trial NCT07042438Trial NCT07040982Trial NCT07037004Trial NCT07025564Trial NCT07025538Trial NCT07020533Trial NCT07003100Trial NCT06996119Trial NCT06985784Trial NCT06954831Trial NCT06922604Trial NCT06918431Trial NCT06910761Trial NCT06860815Trial NCT06859008Trial NCT06834126Trial NCT06815029Trial NCT06815003Trial NCT06780787Trial NCT06763341Trial NCT06763328Trial NCT06735690Trial NCT06735664Trial NCT06731894Trial NCT06675136Trial NCT06675123Trial NCT06672224Trial NCT06626256Trial NCT06625619Trial NCT06581211Trial NCT06580015Trial NCT06575725Trial NCT06575686Trial NCT06575296Trial NCT06572631Trial NCT06572618Trial NCT06572605Trial NCT06549478Trial NCT06543381Trial NCT06538389Trial NCT06500377Trial NCT06498973Trial NCT06454409Trial NCT06454383Trial NCT06453044Trial NCT06447987Trial NCT06440850Trial NCT06408220Trial NCT06399419Trial NCT06328621Trial NCT06287944Trial NCT06260033Trial NCT06249282Trial NCT06196008Trial NCT06195891

Abstract

Developmental Funds ABSTRACT The City of Hope Comprehensive Cancer Center requests CCSG developmental funds to support pilot research projects and developing an additional new shared resources to strengthen research initiatives and promote basic, translational and clinical science research activities. Funding pilot projects and developing shared resources will collectively enhance the ability of the COHCCC to serve the catchment area and mitigate the impact of cancer in the region. COHCCC believes that these activities will enable the Cancer Center to provide the optimal environment to focus the power of precision medicine, basic science inquiry, drug discovery and development, and behavioral interventions to decrease cancer incidence, morbidity, and mortality. The plan for the next funding cycle is to develop a new Multi-Scale Translational Research Core. Multi-scale modeling uses computational analysis to integrate linked measurements made at different scales of measurement (populations, individuals, microenvironment, cells, DNA/RNA/protein, and analytes). Over the past 3 years, the scope City of Hope Comprehensive Cancer Center (COHCCC) Cancer Control and Population Science (CCPS) research has expanded beyond classic epidemiologic testing of associations in large cohorts to biology-focused, translational multi-disciplinary studies that integrate multi-scale data from cohorts with mechanistic mouse-human co-studies, omics (genetics, genomics, proteomics), and analytes (drug levels, endocrine disruptors, carcinogens). The Multi-Scale Translational Research (MSTR) Core in development aims to provide services that facilitate and enhance NCI funded multi-scale research at each level of scale (zip code, individuals, microenvironment, cells, DNA/RNA/protein, and analytes). Multi-scale modeling requires integration of large data sets; to this end, the Core will provide services in data curation, annotation, validation, and assessment of rigor. To support NIH funded COHCCC multi-scale projects, the MSTR Core in development will 1) offer unique services and 2) collaborate and integrate with COHCCC Cores and Caltech, ORIONTM, and TGenTM partners. Unique services offered by the MSTR Core in development include 1) expertise in multi-scale modeling, 2) curation, annotation, and validation of the rigor, reproducibility, and accuracy of tissue, omic, and analyte data, 3) genetic admixture assessment, 4) navigation of existing COH analyte services, 4) expertise in custom tissue engineering and microenvironment studies, 5) cloud-based image storage and sharing services for national and international cohort development. The MSTR in development will deliver this wide range of services through a dedicated team of senior scientists with expertise in precision medicine, tissue engineering, genetic admixture, analyte identification, bioinformatics, and multi-scale modeling.

View original record on NIH RePORTER →